Laparoscopic hysterectomy with or without pelvic lymphadenectomy or sampling in a high-risk series of patients with endo
- PDF / 227,721 Bytes
- 5 Pages / 610 x 792 pts Page_size
- 96 Downloads / 250 Views
BioMed Central
Open Access
Research
Laparoscopic hysterectomy with or without pelvic lymphadenectomy or sampling in a high-risk series of patients with endometrial cancer Susan F Willis, Desmond Barton and Thomas EJ Ind* Address: Department of Gynaecological Oncology, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK Email: Susan F Willis - [email protected]; Desmond Barton - [email protected]; Thomas EJ Ind* - [email protected] * Corresponding author
Published: 13 September 2006 International Seminars in Surgical Oncology 2006, 3:28
doi:10.1186/1477-7800-3-28
Received: 23 May 2006 Accepted: 13 September 2006
This article is available from: http://www.issoonline.com/content/3/1/28 © 2006 Willis et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract Background: The purpose of the study was to determine the outcome of all patients with endometrial adenocarcinoma cancer treated by laparoscopic hysterectomy at our institution, many of whom were high-risk for surgery. Methods: Data was collected by a retrospective search of the case notes and Electronic Patient Records of the thirty eight patients who underwent laparoscopic hysterectomy for endometrial cancer at our institutions. Results: The median body mass index was 30 (range 19–67). Comorbidities were present in 76% (29 patients); 40% (15 patients) had a single comorbid condition, whilst 18% (7 patients) had two, and a further 18% (7 patients) had more than two. Lymphadenectomy was performed in 45% (17 patients), and lymph node sampling in 21% (8 patients). Median operating time was 210 minutes (range 70–360 minutes). Median estimated blood loss was 200 ml (range 50–1000 ml). There were no intraoperative complications. Post-operative complications were seen in 21% (2 major, 6 minor). Blood transfusion was required in 5% (2 patients). The median stay was 4 post-operative nights (range 1–25 nights). In those patients undergoing lymphadenectomy, the mean number of nodes taken was fifteen (range 8–26 nodes). The pathological staging was FIGO stage I 76% (29 patients), stage II 8% (3 patients), stage III 16% (6 patients). The pathological grade was G1 31% (16 patients), G2 45% (17 patients), G3 24% (8 patients). Conclusion: Laparoscopic hysterectomy can be safely carried out in patients at high risk for surgery, with no compromise in terms of outcomes, whilst providing all the benefits inherent in minimal access surgery.
Background The gold standard for staging and preliminary treatment of endometrial cancer (EC) is surgical [1]. Surgery consists of laparotomy, peritoneal washings, hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy or sampling. The role of lymphadenectomy has
been dependant on histology, radiological findings, and local policy.
Data Loading...
